United States· US:68788-4013_4cc1d80b-2435-404f-949f-bd207a863631
Diclona
A medicinal product containing diclofenac sodium; lidocaine, registered in United States by Preferred Pharmaceuticals Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DICLOFENAC SODIUM; LIDOCAINE
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1168788-4013-9
- ndc11687884013999 g in 1 TUBE (68788-4013-9)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Diclofenac sodium; lidocaine in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandDiclo-Acino 75, Injektionslösung i.m.Acino Pharma AG
- PolandDicloratioratiopharm GmbH
- GermanyDiclofenac RatiopharmRatiopharm Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Diclofenac Ratiopharm
- Lithuania · Olfen
- Luxembourg · Diclofenac Ratiopharm®
- Latvia · Olfen
- Poland · Olfen 75
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e915b9ea-2c60-4789-9a8e-f7d42a40d89b GET /v1/drugs/e915b9ea-2c60-4789-9a8e-f7d42a40d89b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "CUTANEOUS",
"source": "ndc",
"strength": ".01; .045",
"substance": "DICLOFENAC SODIUM; LIDOCAINE",
"productndc": "68788-4013",
"dosage_form": "GEL",
"dea_schedule": null,
"strength_unit": "g/g; g/g",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about diclofenac sodium; lidocaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.